Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia

TP53 mutations are strong predictors of poor survival and refractoriness in chronic lymphocytic leukemia (CLL) and have direct implications for disease management. Clinical information on TP53 mutations is limited to lesions represented in >20% leukemic cells. Here, we tested the clinical impact...

詳細記述

保存先:
書誌詳細
主要な著者: Rossi, Davide, Khiabanian, Hossein, Spina, Valeria, Ciardullo, Carmela, Bruscaggin, Alessio, Famà, Rosella, Rasi, Silvia, Monti, Sara, Deambrogi, Clara, De Paoli, Lorenzo, Wang, Jiguang, Gattei, Valter, Guarini, Anna, Foà, Robin, Rabadan, Raul, Gaidano, Gianluca
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2014
主題:
Plenary Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4017291/
https://ncbi.nlm.nih.gov/pubmed/24501221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-11-539726
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料